SCHEMBL19008882

SCHEMBL19008882

CC1(C)c2ccccc2-c2cnc(-c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ IRAK1 P51617 4/20 0.33
▸ SMN1; SMN2 Q16637 4/20 0.33
▸ IRAK4 Q9NWZ3 3/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19008936 0.96 NPC1 (0.34) L3MBTL1KMT2AADORA3ALOX15TSHR
SCHEMBL19008890 0.93 L3MBTL1 (0.39) L3MBTL1KMT2AADORA3ALOX15TSHR
SCHEMBL19008925 0.92 ADORA2A (0.36) L3MBTL1KMT2AADORA3ALOX15TSHR
SCHEMBL19008857 0.92 MEN1 (0.40) L3MBTL1KMT2ATSHRADORA2AADORA1
SCHEMBL19008916 0.91 ADORA2A (0.35) L3MBTL1KMT2AADORA3ALOX15TSHR
SCHEMBL19008877 0.91 MEN1 (0.39) KMT2AADORA2AADORA1SMN1; SMN2NPC1
SCHEMBL19008872 0.89 MAPT (0.35) L3MBTL1TSHRIRAK1SMN1; SMN2IRAK4
SCHEMBL19008884 0.88 MEN1 (0.43) KMT2AADORA2AADORA1SMN1; SMN2NPC1
SCHEMBL19008853 0.87 MEN1 (0.42) KMT2AADORA2AADORA1SMN1; SMN2NPC1
SCHEMBL19008922 0.87 CYP19A1 (0.36) KMT2AADORA3ADORA2BADORA1IRAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10461262-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-29 — — US disclosed
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10461262-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 L3MBTL1 1565/4885KMT2A 2042/4885ADORA3 4789/4885
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 L3MBTL1 1565/4885KMT2A 2042/4885ADORA3 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback